M erkel cell carcinoma (MCC), an uncommon and highly aggressive cutaneous malignancy, usually occurs on the sundamaged skin of the elderly and is characterized by coexpression of neuroendocrine markers and CK20, a discriminant from other types of visceral neuroendocrine neoplasias. Since the discovery of Merkel cell polyomavirus (MCV), many researchers have confirmed its presence in about 80% of cutaneous MCCs. 1 Although some cutaneous MCCs were reported to be associated with squamous cell carcinomas (SCCs), such combined cases accounted for only a minor portion and the viral status appeared to be different from pure MCC. [1] [2] [3] [4] Rarely, primary MCCs occur on the female vulva, 5 with or without combined SCCs, 6 ,7 the latter is often human papillomavirus (HPV) related.
CASE REPORT
A 63-year-old woman had a vulvar tumor over the right labium majus for 5 years, with recent enlargement and pain. The erosive exophytic tumor measured 5 cm in its greatest dimension. No other cutaneous lesions were found. The excision specimen consisted of a nodular dermal tumor measuring 3.6 3 2.5 3 1.3 cm in size with an eroded surface and irregular tumor borders. Microscopically, the tumor was biphasic and composed of: (1) a moderately differentiated malignant squamous cell component with keratin pearl formation; and (2) a poorly differentiated basophilic malignancy consisting of cells in sheetlike pattern with high nucleocytoplasmic ratio, vesicular nuclei, and small to occasionally prominent nucleoli. Comedo necrosis was common, without peripheral palisading. There was an abrupt transition from the squamous component to the blue cell component (Fig 1) . Immunohistochemically, the basophilic tumor cells expressed an immunoprofile of synaptophysin (Fig 2) , whereas the squamous part was synaptophysin
1 , consistent with a primary tumor of combined SCC and MCC. Both parts were negative to MCV large T-antigen (CM2B4) antibody (sc-136172, Santa Cruz Biotechnology, Dallas, TX) (dilution 1:50). P53 was overexpressed in both components.
Genomic DNA from both components was collected from paraffin blocks via manual microdissection for HPV and MCV detection by polymerase chain reaction (PCR) and TP53 gene mutation by direct sequencing. To increase the chance for MCV (Fig 3) or inactivating mutation in the TP53 was detected. By contrast, an identical clone of type-16 HPV in both components was identified (Fig 3) . To eliminate possible cross-contamination, we validated the result by RNAscope in situ hybridization to detect HPV E6/E7 messenger RNA expression on slides and identified cytoplasmic punctate dots in both components (Fig 1) .
DISCUSSION
MCC, known as a primary neuroendocrine carcinoma of the skin, tends to affect the elderly and is associated with chronic sun damage, immunosuppression, or both. Feng et al 9 first demonstrated the clonal integration of MCV DNA in the cutaneous MCC tumor cells. Later, several studies indicated that no MCV DNA was detected in other visceral high-grade neuroendocrine carcinomas. These discoveries stressed the oncogenic role of MCV in cutaneous MCCs. However, there are insufficient data regarding the role of MCV in MCCs arising from unusual sun-protected regions of the body. In the current case, a combined SCC component raises the suspicion of HPV DNA integration, rather than MCV DNA, as the pathogenesis of vulvar MCC development. We have determined this by PCR demonstrating the 2 malignant components (squamous and neuroendocrine) incorporating the same high-risk HPV DNA in their genome, but no MCV DNA. Moreover, combined squamous and neuroendocrine carcinomas of skin in sun-damaged regions share ultraviolet lighterelated TP53 mutations in both components, 10 whereas in the current case the TP53 mutation is lacking, further supporting the concept of MCV-independent and HPV-related tumorigenesis in vulvar MCCs. Vulvar MCC is extremely rare with fewer than 20 cases reported in the English-language medical literature. 6, 7 However, neuroendocrine carcinoma of the uterine cervix is a well-established entity that is highly correlated with HPV type-18 infection. 11 Generally, 2 major pathogenetic routes are linked to the development of vulvar carcinoma, ie, HPV infection and inflammatory dermatoses. The result from this study suggests that a portion of vulvar MCC is HPV related (cervical type), whereas the other portion is more akin to usual cutaneous MCV-related MCC (cutaneous type). An association with basaloidtype (or moderately to poorly differentiated) SCC may argue for the former, whereas an association with well-differentiated SCC or dermatoses may suggest the latter. Unfortunately, the reported vulvar MCC cases in English-language literature seldom included this information, and tests for HPV and MCV were rarely done (Table I) . The current case suggests that a subset of vulvar MCC is HPV related. This also suggests that the phenotype of MCC might represent a distinctive pathway of HPV-related tumorigenesis in certain body regions. Interestingly, Schrama et al 12 recently found the coexistence of MCV and HPV DNA in mutation-specific BRAF inhibitor-induced epithelial proliferations. This raises the suspicion that an epigenetic scenario of MCV ''hit-and-run tumorigenesis'' might also be considered in the current case. Based on the experiences from cutaneous MCCs, patients with combined SCC and MCC matched pure MCC in clinical aggressiveness. They tended to progress rapidly and have metastatic foci with pure neuroendocrine features. As for the patients with vulvar MCC, most of the patients died within the first 2 years after diagnosis. Our patient died of cancer-related cachexia and infection 6 months after initial diagnosis. Chemotherapy and radiotherapy provided only limited benefits. However, our case implicates that prophylactic vaccination against oncogenic HPV could prevent not only anogenital SCC, but also certain cases of HPV-associated vulvar/genital MCC. With efforts to elucidate the pathogenesis of vulvar MCCs (eg, HPV, MCV, ultraviolet related), further individualized therapy could be expected.
